Scarica l'app Stockscreener
127.13
1.76%
-2.32
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Abbott Laboratories Borsa (ABT) Ultime notizie
Abbott (ABT) Margin Surge Reinforces Bullish Narratives Despite Earnings Decline Forecast - Yahoo
Abbott Laboratories’ Earnings Call Highlights Strong Growth - TipRanks
Strong Performance and Future Potential: Buy Rating for Abbott Laboratories - TipRanks
Why Abbott Laboratories (ABT) Stock Is Down Today - The Globe and Mail
Gold Gains Over 1%; Abbott Shares Fall After Q3 Results - Benzinga
Abbott Laboratories (ABT) Q3 2025 Earnings Call Highlights: Stro - GuruFocus
Abbott narrows outlook, Australian stocks react to US-China trade - Yahoo Finance
Abbott Laboratories (ABT) Sees Robust Growth in Q3 2025 - GuruFocus
Abbott CEO: ‘We’re right on time’ to the PFA party - MedTech Dive
Abbott Q3 results come up shy of sales forecast, Medical Device sales grow 15% - MassDevice
Abbott Laboratories' Q3 2025 Results: Steady Performance with Limited Upside - GuruFocus
Is it Time to Buy the Abbott Labs Dip? - TheStreet Pro
Abbott Labs Q3 2025 presentation: organic growth solid despite market challenges - Investing.com Australia
Earnings call transcript: Abbott Labs Q3 2025 sees stable EPS, stock dips - Investing.com
Abbott revenue misses as diagnostics, nutrition weakness clouds medical devices lift - Reuters
Abbott Laboratories Remains In Favor With London Investment Manager, New Filing Shows - The Motley Fool
Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over? - ts2.tech
Medical device business accelerates but diagnostics 'lose momentum'; Abbott Laboratories' performance falls short of expectations. - 富途牛牛
1 No-Brainer Dividend Stock to Buy and Hold Forever - AOL.com
Abbott (ABT) Stock Falls Despite Meeting Earnings Expectations – Here’s Why - parameter.io
Abbott's Q3 Earnings Meet Estimates, Revenues Up Y/Y, Stock Climbs - Yahoo Finance
S&P Health Giant Skids On Mixed Third-Quarter News - Investor's Business Daily
Abbott Laboratories posts steady sales growth in Q3, reaffirms full-year guidance - Proactive financial news
ABT Sees Growth from New Products and Biosimilars - GuruFocus
Abbott Cuts Top End of 2025 Guidance as Tariff Threat Looms - Bloomberg.com
Abbott Laboratories reports results for the quarter ended September 30Earnings Summary - TradingView
Here's What Key Metrics Tell Us About Abbott (ABT) Q3 Earnings - Yahoo
Abbott Tightens Annual Sales Forecast As Q3 Sales Miss Expectations - inkl
Abbott Laboratories Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Abbott Laboratories (ABT) Faces Revenue Shortfall Despite Earnin - GuruFocus
Abbott Laboratories (ABT) Anticipates Earnings Surge - GuruFocus
Stock Market Today: S&P 500, Nasdaq Futures Rise— Bank Of America, Morgan Stanley, Abbott Earnings In Focus (UPDATED) - Benzinga
Abbott Laboratories Revises Annual Earnings Outlook In Line With View; Stock Down In Pre-Market - Nasdaq
Abbott Posts Steady Growth As Medical Devices Shine - Finimize
Earnings Snapshot: Abbott Laboratories Q3 misses revenue estimates; narrows FY profit outlook range - MSN
Abbott in charts: Medical Devices continues to see Y/Y double-digit growth momentum in Q3, up 14.8% - MSN
Abbott Laboratories down after Q3 topline miss - MSN
Abbott Posts Solid Earnings, Adult Nutrition Drives Sales. The Stock Drops Anyway. - MSN
Abbott (ABT) Q3 Earnings Meet Estimates - Yahoo
Abbott revenue falls short of estimates on weak demand for diagnostic devices - Yahoo
Abbott Laboratories stock down on Q3 topline miss (ABT:NYSE) - Seeking Alpha
Abbott Reaffirms Earnings Guidance for the Year 2025 - MarketScreener
Abbott misses revenue expectations on weak demand for diagnostic devices - MSN
Abbott Laboratories (ABT) Reports Mixed Q3 Results - GuruFocus
Abbott (ABT) Maintains 2025 Sales and EPS Forecasts - GuruFocus
Abbott (ABT) Posts Slight Miss on Q3 Revenue Expectations - GuruFocus
Abbott Laboratories Q3 Earnings: Adjusted EPS of $1.30 Beats Est - GuruFocus
Abbott reports in-line third-quarter results, affirms guidance; shares slip - Investing.com
Abbott Laboratories (NYSE:ABT) Reports Q3 In Line With Expectations - TradingView
Abbott Labs Posts Higher Sales, Reaffirms Outlook - The Wall Street Journal
Abbott Laboratories Q3 Adjusted Earnings, Net Sales Rise; Fiscal 2025 Non-GAAP EPS Guidance Narrowed - MarketScreener
Abbott meets Q3 profit estimates, narrows full-year profit forecast - MarketScreener
Abbott Labs earnings matched, revenue fell short of estimates By Investing.com - Investing.com Nigeria
Abbott: Q3 Earnings Snapshot - The Pantagraph
Abbott posts higher quarterly revenue on strong medical device demand - Yahoo Finance
Abbott Labs earnings matched, revenue fell short of estimates - Investing.com
Abbott Revenue Falls Short of Estimates on Weak Demand for Diagnostic Devices - Money US News.com
Abbott Reports Third-Quarter 2025 Results - TradingView
(ABT) Abbott Laboratories Expects 2025 Adjusted EPS Range $5.12 to $5.18, vs. FactSet Est of $5.15 - MarketScreener
Earnings Flash (ABT) Abbott Laboratories Posts Q3 Adjusted EPS $1.30 per Share, vs. FactSet Est of $1.30 - MarketScreener
Earnings Flash (ABT) Abbott Laboratories Reports Q3 Revenue $11.37B, vs. FactSet Est of $11.39B - MarketScreener
Abbott Labs posts Q3 sales of $11.4B, up 6.9% - breakingthenews.net
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):